← Back to ATC View

L04AA - Selective immunosuppressants

Substances (36)

L04AA02 - muromonab-CD3 (P)

L04AA03 - antilymphocyte immunoglobulin (horse)

L04AA04 - antithymocyte immunoglobulin (rabbit) (P)

L04AA06 - mycophenolic acid (O)

L04AA06 - mycophenolic acid (P)

L04AA10 - sirolimus (O)

L04AA13 - leflunomide (O)

L04AA15 - alefacept

L04AA18 - everolimus (O)

L04AA19 - gusperimus

L04AA21 - efalizumab (P)

L04AA22 - abetimus

L04AA23 - natalizumab (P)

L04AA24 - abatacept (P)

L04AA25 - eculizumab (P)

L04AA26 - belimumab (P)

L04AA27 - fingolimod (O)

L04AA28 - belatacept (P)

L04AA29 - tofacitinib (O)

L04AA31 - teriflunomide (O)

L04AA32 - apremilast (O)

L04AA33 - vedolizumab (P)

L04AA34 - alemtuzumab (P)

L04AA35 - begelomab

L04AA36 - ocrelizumab (P)

L04AA37 - baricitinib (O)

L04AA38 - ozanimod

L04AA39 - emapalumab

L04AA40 - cladribine (O)

L04AA41 - imlifidase

L04AA42 - siponimod

L04AA43 - ravulizumab

L04AA44 - upadacitinib

L04AA45 - filgotinib

L04AA46 - itacitinib

L04AA47 - inebilizumab